We serve Chemical Name:2-Cyano-N-cyclohexylacetamide CAS:15029-38-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Cyano-N-cyclohexylacetamide
CAS.NO:15029-38-6
Synonyms:2-Cyano-N-cyclohexyl-acetamide;2-Cyano-N-cyclohexylacetamide;N-cyclohexyl-2-cyano-acetamide;N1-cyclohexyl-2-cyanoacetamide;Cyanessigsaeure-cyclohexylamid;N-cyclohexyl(cyano)acetamide;Acetamide, 2-cyano-N-cyclohexyl-
Molecular Formula:C9H14N2O
Molecular Weight:166.220
HS Code:2926909090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:381.1±21.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.485
PSA:52.89000
Exact Mass:166.110611
LogP:0.49
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Cyano-N-cyclohexyl-acetamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Acetamide, 2-cyano-N-cyclohexyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Cyano-N-cyclohexylacetamide Use and application,N-cyclohexyl-2-cyano-acetamide technical grade,usp/ep/jp grade.
Related News: There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect. 2-Cyano-N-cyclohexylacetamide manufacturer At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs. 2-Cyano-N-cyclohexylacetamide supplier At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs. 2-Cyano-N-cyclohexylacetamide vendor he agency said the drugmaker and Emergent must agree that the FDA can share relevant information about the manufacturing of the doses with regulators where the vaccine is shipped. 2-Cyano-N-cyclohexylacetamide factory The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo.
